Status:

COMPLETED

(Re)Vitalizing Pulmonary Rehabilitation for Patients With Chronic Respiratory Diseases

Lead Sponsor:

Aveiro University

Collaborating Sponsors:

Fundação para a Ciência e a Tecnologia

Conditions:

Chronic Respiratory Disease

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

3R aims to increase the access of patients with chronic respiratory diseases (CRD) to pulmonary rehabilitation (PR) in Portugal. The main goals of 3R are: i) design and implement an innovative communi...

Detailed Description

More than 1 billion people suffer from chronic respiratory diseases worldwide and, in Europe, the total annual cost of respiratory diseases amounts to more than €380 billion. In Portugal, respiratory ...

Eligibility Criteria

Inclusion

  • clinical diagnosis of a chronic respiratory disease
  • clinically stable in the previous month
  • ≥ 18 years old
  • able to provide their own informed consent

Exclusion

  • cognitive impairments
  • inability to understand and co-operate
  • history of neoplasic /immunologic disease or acute cardiac condition or a significant cardiac, musculoskeletal, neuromuscular or psychiatric condition.

Key Trial Info

Start Date :

January 7 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 30 2020

Estimated Enrollment :

146 Patients enrolled

Trial Details

Trial ID

NCT03799666

Start Date

January 7 2019

End Date

June 30 2020

Last Update

July 8 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Aveiro

Aveiro, Portugal, 3810-193